Clinical trial Recruiting at 1 site Observational Ages 18 and up

Minimally invasive treatments for thyroid cancer

Official title: Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma

Run by European Institute of Oncology · NCT06333587 · Data updated 2026-11-12

This study is testing whether less invasive treatments for small thyroid cancers can safely replace surgery and improve patients' quality of life.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment270 (estimated)
SponsorEuropean Institute of Oncology
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedOctober 10, 2022
Main results expectedDecember 31, 2025
Study endsDecember 31, 2035
Registry record updatedMarch 27, 2024
Trial IDNCT06333587 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years with a cytologically proven diagnosis of Papillary Thyroid Microcarcinoma suitable for minimally invasive treatments.

Probably not a fit

Patients with tumors larger than 1 cm or those with other types of thyroid cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the use of minimally invasive treatments, specifically image-guided thermal ablations, as an alternative to surgery for patients diagnosed with Papillary Thyroid Microcarcinoma (PTMC). It aims to establish a prospective registry to validate the safety and efficacy of these treatments while collecting long-term results from a large cohort of patients. The approach is designed to minimize complications and improve quality of life by precisely targeting the tumor while sparing surrounding thyroid tissue.

Why it matters

Potential benefit: If successful, this could provide a less invasive treatment option for patients with Papillary Thyroid Microcarcinoma, leading to fewer complications and improved quality of life.

How similar studies have gone: Other studies have shown promising results with similar minimally invasive approaches, indicating potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients \> 18years
* Patients with diagnosis of papillary thyroid microcarcinoma, citologically proven, suitable for MITT.
* Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
* Patients must be accessible for follow-up

Exclusion Criteria:

* Tumors \> 1 cm, other citological type, refusal of MITT, unsuitable for MITT, unmanageable coagulative disorders
* Patients with psychiatric, addictive, or any disorder, which compromises ability to give informed consent for participation in this study

Where it's running

  • European Institute of Oncology
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.